ALX Alexander's, Inc.
Price Chart
Executive Summary
Alexander's, Inc. completed the sale of its Rego Park I property in Queens, NY to Northwell Health for a gross price of $235.5 million, generating net proceeds of $203 million. The company will recognize a financial statement gain of approximately $148 million in Q2 2026, with a tax gain of about $145 million split between 2025 and 2026. This sale reduces Alexander's portfolio to four properties in New York City, representing a significant asset monetization.
Key Financial Metrics
Actionable Insight
The sale provides a large one-time gain and cash inflow, but reduces the property base to four assets. Monitor for any reinvestment plans or special dividends from the proceeds, as the company's future earnings power will depend on the remaining portfolio's performance.
Key Facts
- Gross sales price of $235.5 million for Rego Park I property
- Net proceeds of $203 million after $21 million of costs paid prior to closing
- Financial statement gain of approximately $148 million to be recognized in Q2 2026
- Tax gain of approximately $145 million, with $48 million recognized in 2025 and $97 million in 2026
- Buyer is Northwell Health, Inc.
- Alexander's now has four properties in New York City
Financial Impact
Gain of $148 million (financial statement) and $145 million (tax) on a $235.5 million gross sale; net proceeds of $203 million.
Risk Factors
- Reduced property count increases concentration risk in remaining four NYC properties
- One-time gain may mask underlying operational trends; focus on core FFO from remaining assets
- No disclosure of use of proceeds — potential for shareholder return or reinvestment uncertainty
Market Snapshot
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3303307 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 28, 2026
15d ago
|
Press Release
| $246.11 $258.59 | ▲ +5.07% | ▲ +7.59% | $262.60 (+6.70%) |
|
May 21, 2026
22d ago
|
8-K
| $246.22 $247.05 | ▲ +0.34% | ▼ −1.32% | $262.60 (+6.65%) |
|
May 4, 2026
5w ago
|
Press Release
| $239.36 $236.70 | ▲ +1.11% | ▲ +4.05% | $262.60 (−9.71%) |
|
Apr 29, 2026
6w ago
|
Press Release
| $245.53 $251.27 | ▲ +2.34% | ▼ −0.77% | $262.60 (+6.95%) |
|
Apr 21, 2026
7w ago
|
Press Release
| $247.43 $249.08 | ▲ +0.67% | ▼ −0.42% | $262.60 (+6.13%) |
|
Apr 7, 2026
9w ago
|
DEFA14A
| $235.45 $244.21 | ▲ +3.72% | ▲ +0.20% | $262.60 (+11.53%) |
|
Mar 9, 2026
13w ago
|
Press Release
| $235.92 $243.28 | ▲ +3.12% | ▲ +4.47% | $262.60 (+11.31%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access